Can a vitamin B3 pill help fight Alzheimer's? new study aims to find out

NCT ID NCT06582706

Recruiting now Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Mar 22, 2026 · Last updated May 21, 2026 · Updated 8 times

Summary

This study looks at whether a common vitamin (niacin) can get into the brain fluid of people with mild-to-moderate Alzheimer's disease. Researchers will give 30 volunteers a single 500 mg dose of extended-release niacin and measure its levels in blood and spinal fluid. The goal is to see if niacin can reach brain cells, which may help design future treatments. This is an early-stage study focused on safety and how the drug works in the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

IU Health Neuroscience Center
RECRUITING

Indianapolis, Indiana, 46202, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ALZHEIMER DISEASE